Current Concepts in the Treatment of Rheumatoid Arthritis
Identifieur interne : 003438 ( Main/Exploration ); précédent : 003437; suivant : 003439Current Concepts in the Treatment of Rheumatoid Arthritis
Auteurs : Daniel G. Baker [États-Unis] ; Joseph L. Rabinowitz [États-Unis]Source :
- The Journal of Clinical Pharmacology [ 0091-2700 ] ; 1986-01.
English descriptors
- Teeft :
- Acetylsalicylic, Acetylsalicylic acid, Adverse effects, Antibody production, Aplastic anemia, Arthritis, Arthritis rheum, Aseptic necrosis, Aspirin, Auranofin, Azathioprine, Benign intracranial hypertension, Cause leukopenia, Cellular immunity, Chelating agent, Clin, Clinical efficacy, Clinical significance, Collagen crosslinking, Complete blood counts, Complication, Congestive heart failure, Convincing evidence, Corticosteroid, Cyclophosphamide, Definite improvement, Dos, Dosage, Drug efficacy, Drug interactions, Drug therapy, Empire rheumatism study, Endoscopic evaluation, Excretion, Experimental therapies, Gastric, Gastric mucosa, Gold compounds, Gold salts, Gold sodium thiomalate, Gold therapy, Health statistics, Hearing loss, High doses, Higher doses, Immune, Immunocompetent cells, Immunologic, Immunologic process, Indomethacin, Inflammation, Inhibition, Intern, Large amounts, Large number, Leukopenia, Liver disease, Local steroids, Lower dose, Lymphocyte, Lymphocyte proliferation, Many drugs, Metabolism, Methotrexate, Nonsteroidal, Nonsteroidal agent, Nsaid, Older patients, Other drugs, Other mechanisms, Other medications, Other nsaids, Parenteral gold, Peak levels, Penicillamine, Pharmacol, Plasma cells, Plasma levels, Platelet, Proc, Progression, Prostaglandin, Prostaglandin production, Protein sulfhydryl, Proteinuria, Pulmonary disease, Rabinowitz, Radiologic, Radiologic changes, Radiologic progression, Rash, Renal, Renal blood flow, Renal disease, Rheum, Rheumatic, Rheumatic disease, Rheumatic diseases, Rheumatoid, Rheumatoid arthritis, Rheumatoid disease, Rheumatoid factor, Rheumatoid factors, Rheumatoid nodules, Salicylate, Same time, Semin arthritis rheum, Serum level, Several days, Several patients, Several studies, Side effects, Significant difference, Significant improvement, Significant incidence, Significant side effects, Small differences, Special problems, Steroid, Steroid administration, Steroid preparations, Syndrome, Synovial, Synovium, Therapeutic review, Therapeutic review arthritis, Therapy, Tinnitus, Total dose, Toxicity, Uncontrolled studies, Uric acid, Urinary excretion, Urine, Vascular permeability, Vexing problem.
Url:
DOI: 10.1002/j.1552-4604.1986.tb02896.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000379
- to stream Istex, to step Curation: 000379
- to stream Istex, to step Checkpoint: 002197
- to stream Main, to step Merge: 003511
- to stream Main, to step Curation: 003438
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Current Concepts in the Treatment of Rheumatoid Arthritis</title><author><name sortKey="Baker, Daniel G" sort="Baker, Daniel G" uniqKey="Baker D" first="Daniel G." last="Baker">Daniel G. Baker</name></author><author><name sortKey="Rabinowitz, Joseph L" sort="Rabinowitz, Joseph L" uniqKey="Rabinowitz J" first="Joseph L." last="Rabinowitz">Joseph L. Rabinowitz</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F4E278F95B6831446B43C6844C0A5C9474525881</idno><date when="1986" year="1986">1986</date><idno type="doi">10.1002/j.1552-4604.1986.tb02896.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-ZCSFVVJ9-3/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000379</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000379</idno><idno type="wicri:Area/Istex/Curation">000379</idno><idno type="wicri:Area/Istex/Checkpoint">002197</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002197</idno><idno type="wicri:doubleKey">0091-2700:1986:Baker D:current:concepts:in</idno><idno type="wicri:Area/Main/Merge">003511</idno><idno type="wicri:Area/Main/Curation">003438</idno><idno type="wicri:Area/Main/Exploration">003438</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Current Concepts in the Treatment of Rheumatoid Arthritis</title><author><name sortKey="Baker, Daniel G" sort="Baker, Daniel G" uniqKey="Baker D" first="Daniel G." last="Baker">Daniel G. Baker</name><affiliation></affiliation><affiliation wicri:level="3"><country>États-Unis</country><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName><wicri:orgArea>Veterans Administration Medical Center</wicri:orgArea></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Correspondence address: University and Woodland Avenues, Philadelphia</wicri:cityArea></affiliation></author><author><name sortKey="Rabinowitz, Joseph L" sort="Rabinowitz, Joseph L" uniqKey="Rabinowitz J" first="Joseph L." last="Rabinowitz">Joseph L. Rabinowitz</name><affiliation></affiliation><affiliation wicri:level="3"><country>États-Unis</country><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName><wicri:orgArea>Veterans Administration Medical Center</wicri:orgArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">The Journal of Clinical Pharmacology</title><title level="j" type="alt">JOURNAL OF CLINICAL PHARMACOLOGY</title><idno type="ISSN">0091-2700</idno><idno type="eISSN">1552-4604</idno><imprint><biblScope unit="vol">26</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="2">2</biblScope><biblScope unit="page" to="21">21</biblScope><biblScope unit="page-count">20</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1986-01">1986-01</date></imprint><idno type="ISSN">0091-2700</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0091-2700</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acetylsalicylic</term><term>Acetylsalicylic acid</term><term>Adverse effects</term><term>Antibody production</term><term>Aplastic anemia</term><term>Arthritis</term><term>Arthritis rheum</term><term>Aseptic necrosis</term><term>Aspirin</term><term>Auranofin</term><term>Azathioprine</term><term>Benign intracranial hypertension</term><term>Cause leukopenia</term><term>Cellular immunity</term><term>Chelating agent</term><term>Clin</term><term>Clinical efficacy</term><term>Clinical significance</term><term>Collagen crosslinking</term><term>Complete blood counts</term><term>Complication</term><term>Congestive heart failure</term><term>Convincing evidence</term><term>Corticosteroid</term><term>Cyclophosphamide</term><term>Definite improvement</term><term>Dos</term><term>Dosage</term><term>Drug efficacy</term><term>Drug interactions</term><term>Drug therapy</term><term>Empire rheumatism study</term><term>Endoscopic evaluation</term><term>Excretion</term><term>Experimental therapies</term><term>Gastric</term><term>Gastric mucosa</term><term>Gold compounds</term><term>Gold salts</term><term>Gold sodium thiomalate</term><term>Gold therapy</term><term>Health statistics</term><term>Hearing loss</term><term>High doses</term><term>Higher doses</term><term>Immune</term><term>Immunocompetent cells</term><term>Immunologic</term><term>Immunologic process</term><term>Indomethacin</term><term>Inflammation</term><term>Inhibition</term><term>Intern</term><term>Large amounts</term><term>Large number</term><term>Leukopenia</term><term>Liver disease</term><term>Local steroids</term><term>Lower dose</term><term>Lymphocyte</term><term>Lymphocyte proliferation</term><term>Many drugs</term><term>Metabolism</term><term>Methotrexate</term><term>Nonsteroidal</term><term>Nonsteroidal agent</term><term>Nsaid</term><term>Older patients</term><term>Other drugs</term><term>Other mechanisms</term><term>Other medications</term><term>Other nsaids</term><term>Parenteral gold</term><term>Peak levels</term><term>Penicillamine</term><term>Pharmacol</term><term>Plasma cells</term><term>Plasma levels</term><term>Platelet</term><term>Proc</term><term>Progression</term><term>Prostaglandin</term><term>Prostaglandin production</term><term>Protein sulfhydryl</term><term>Proteinuria</term><term>Pulmonary disease</term><term>Rabinowitz</term><term>Radiologic</term><term>Radiologic changes</term><term>Radiologic progression</term><term>Rash</term><term>Renal</term><term>Renal blood flow</term><term>Renal disease</term><term>Rheum</term><term>Rheumatic</term><term>Rheumatic disease</term><term>Rheumatic diseases</term><term>Rheumatoid</term><term>Rheumatoid arthritis</term><term>Rheumatoid disease</term><term>Rheumatoid factor</term><term>Rheumatoid factors</term><term>Rheumatoid nodules</term><term>Salicylate</term><term>Same time</term><term>Semin arthritis rheum</term><term>Serum level</term><term>Several days</term><term>Several patients</term><term>Several studies</term><term>Side effects</term><term>Significant difference</term><term>Significant improvement</term><term>Significant incidence</term><term>Significant side effects</term><term>Small differences</term><term>Special problems</term><term>Steroid</term><term>Steroid administration</term><term>Steroid preparations</term><term>Syndrome</term><term>Synovial</term><term>Synovium</term><term>Therapeutic review</term><term>Therapeutic review arthritis</term><term>Therapy</term><term>Tinnitus</term><term>Total dose</term><term>Toxicity</term><term>Uncontrolled studies</term><term>Uric acid</term><term>Urinary excretion</term><term>Urine</term><term>Vascular permeability</term><term>Vexing problem</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region><settlement><li>Philadelphie</li></settlement></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Baker, Daniel G" sort="Baker, Daniel G" uniqKey="Baker D" first="Daniel G." last="Baker">Daniel G. Baker</name></region><name sortKey="Baker, Daniel G" sort="Baker, Daniel G" uniqKey="Baker D" first="Daniel G." last="Baker">Daniel G. Baker</name><name sortKey="Rabinowitz, Joseph L" sort="Rabinowitz, Joseph L" uniqKey="Rabinowitz J" first="Joseph L." last="Rabinowitz">Joseph L. Rabinowitz</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003438 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003438 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:F4E278F95B6831446B43C6844C0A5C9474525881
|texte= Current Concepts in the Treatment of Rheumatoid Arthritis
}}
| This area was generated with Dilib version V0.6.33. |  |